​

Evolent Health (EVH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

EVH Stock Forecast

Evolent Health (EVH) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $6.38, with a high of $10.00 and a low of $3.50. This represents a 108.50% increase from the last price of $3.06.

- $7 $14 $21 $28 $35 High: $10 Avg: $6.38 Low: $3.5 Last Closed Price: $3.06

EVH Stock Rating

Evolent Health stock's rating consensus is Buy, based on 29 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 23 Buy (79.31%), 6 Hold (20.69%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 29 6 23 0 Strong Sell Sell Hold Buy Strong Buy

EVH Price Target Upside V Benchmarks

TypeNameUpside
StockEvolent Health108.50%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 52.17%

Price Target Trends

1M3M12M
# Anlaysts234
Avg Price Target$4.75$6.50$6.38
Last Closing Price$3.06$3.06$3.06
Upside/Downside55.23%112.42%108.50%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 264102--16
Feb, 264111--16
Jan, 26411---15
Dec, 25411---15
Nov, 25491--14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 25, 2026Truist Financial$6.00$3.0596.72%96.08%
Feb 25, 2026Sean DodgeBMO Capital$3.50$3.0315.51%14.38%
Feb 02, 2026David LarsenBTIG$10.00$3.21211.53%226.80%
Dec 02, 2025Piper Sandler$6.00$3.8456.25%96.08%
Jan 16, 2025Kevin CaliendoUBS$14.00$9.9740.42%357.52%
Jan 15, 2025Jailendra SinghTruist Financial$20.00$9.97100.60%553.59%
Jan 14, 2025Sean DodgeRBC Capital$17.00$11.9642.14%455.56%
Jan 10, 2025Constantine DavidesJMP Securities$18.00$12.5443.54%488.24%
Nov 18, 2024Mohan NaiduOppenheimer$28.00$12.59122.40%815.03%
Oct 17, 2024Jeff GarroStephens$38.00$24.9652.24%1141.83%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 02, 2026Cowen & Co.BuyBuyhold
Feb 25, 2026BMO CapitalOutperformOutperformhold
Feb 02, 2026BTIGBuyBuyhold
Jan 06, 2026CitigroupOutperformOutperformhold
Jan 06, 2026CitigroupMarket OutperformMarket Outperformhold
Aug 28, 2025Piper SandlerOverweightOverweighthold
Jan 16, 2025UBSBuyBuyhold
Jan 14, 2025RBC CapitalOutperformOutperformhold
Jan 10, 2025JMP SecuritiesOutperformOutperformhold
Jan 10, 2025NeedhamBuyinitialise

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.36$-0.20$-1.28$-0.81$-5.07---
Avg Forecast$-0.04$0.86$0.78$0.72$0.78$1.08$1.09$1.52
High Forecast$-0.04$0.90$0.95$0.83$1.45$8.52$1.32$1.84
Low Forecast$-0.04$0.80$0.58$0.62$-0.19$-5.02$0.80$1.12
Surprise %800.00%-123.26%-264.10%-212.50%-750.00%---

Revenue Forecast

$500M $2B $3B $4B $5B $6B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$907.96M$1.35B$1.96B$2.55B$1.88B---
Avg Forecast$890.15M$1.34B$1.95B$2.56B$2.49B$2.85B$3.57B$4.44B
High Forecast$911.83M$1.39B$1.96B$2.97B$2.79B$2.90B$3.66B$5.16B
Low Forecast$861.35M$1.27B$1.55B$2.55B$2.00B$2.80B$3.48B$3.54B
Surprise %2.00%0.70%0.71%-0.19%-24.77%---

Net Income Forecast

$-1B $-600M $-200M $200M $600M $1B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-37.60M$-19.16M$-113.04M$-61.62M$-579.40M---
Avg Forecast$-71.64M$95.83M$-142.26M$80.93M$70.06M$20.70M$117.60M$169.10M
High Forecast$-57.31M$100.19M$-113.81M$92.64M$160.88M$947.68M$146.31M$204.65M
Low Forecast$-85.96M$89.15M$-170.71M$69.21M$-20.76M$-558.89M$88.88M$124.33M
Surprise %-47.51%-120.00%-20.54%-176.15%-926.98%---

EVH Forecast FAQ

Is Evolent Health stock a buy?

Evolent Health stock has a consensus rating of Buy, based on 29 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 23 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Evolent Health is a favorable investment for most analysts.

What is Evolent Health's price target?

Evolent Health's price target, set by 29 Wall Street analysts, averages $6.38 over the next 12 months. The price target range spans from $3.5 at the low end to $10 at the high end, suggesting a potential 108.50% change from the previous closing price of $3.06.

How does Evolent Health stock forecast compare to its benchmarks?

Evolent Health's stock forecast shows a 108.50% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare information services stocks industry (52.17%).

What is the breakdown of analyst ratings for Evolent Health over the past three months?

  • March 2026: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 25.00% Strong Buy, 68.75% Buy, 6.25% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 26.67% Strong Buy, 73.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Evolent Health’s EPS forecast?

Evolent Health's average annual EPS forecast for its fiscal year ending in December 2026 is $1.08, marking a -121.30% decrease from the reported $-5.07 in 2025. Estimates for the following years are $1.09 in 2027, and $1.52 in 2028.

What is Evolent Health’s revenue forecast?

Evolent Health's average annual revenue forecast for its fiscal year ending in December 2026 is $2.85B, reflecting a 51.92% increase from the reported $1.88B in 2025. The forecast for 2027 is $3.57B, and $4.44B for 2028.

What is Evolent Health’s net income forecast?

Evolent Health's net income forecast for the fiscal year ending in December 2026 stands at $20.7M, representing a -103.57% decrease from the reported $-579M in 2025. Projections indicate $117.6M in 2027, and $169.1M in 2028.